24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Is the Mumps Vaccine Becoming Less Effective?Autism Now Diagnosed in 1 in Every 44 Children, CDC SaysKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionAre Your Holiday Gifts on the 'Noisy Toy List'?Many Kids, Teens Think Girls Don't Care About Computer ScienceMost Parents Say Their Kids Aren't Thankful Enough: PollPandemic Curbed Kids' Efforts to Lose Excess WeightClimate Change May Not Increase Allergies in Kids With Asthma: StudyNearly 10% of Younger Kids Have Gotten First COVID Vaccine DoseAHA News: Family-Based Programs Targeting Childhood Obesity Can Be Good for Parents, TooCases of Children's Severe COVID-Linked Illness Were Worse in Second WaveFace Masks Don't Hide Emotions From Kids: StudyTrauma in Childhood Can Harm Health for a Lifetime: StudyAdult 'Picky Eaters' on What Parents Did Right and WrongWHO, CDC Warn of Measles Threat After 22 Million Infants Miss Shots During PandemicWealthier Parents More Likely to Get COVID Vaccines for Young Kids: PollNearly 900,000 U.S. Kids Under 12 Have Gotten Their First COVID ShotNo Evidence Violent Video Games Lead to Real Violence: StudyDo Your Kids Really Need Cough & Cold Meds?AHA News: What Parents Should Know About the COVID-19 Vaccine For 5- to 11-Year-OldsFor Kids Afraid of Needles, These Tips May Help Ease COVID ShotsCDC Signs Off on Pfizer Vaccine for Younger KidsWe've Been Here Before: How Polio Vaccine Rollout Saved Millions of Young LivesVaccinations for Kids Will Be in Full Swing by Nov. 8, White House SaysFDA Approves Pfizer COVID Vaccine for Kids 5-11Attorneys General Warn About Pot Products That Look Like Halloween TreatsCDC Lowers Threshold for Lead Poisoning in Youngest KidsFDA Advisors Approve Emergency Use of Pfizer COVID Vaccine in Kids 5 to 11Moderna Says Its COVID Vaccine Works Well in Children Aged 6 to 11Pediatricians Offer Advice on Keeping Trick-or-Treaters SafeThe No. 1 Cause of Halloween Injuries: Carving the PumpkinPfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDAPfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenWhite House Announces COVID Vaccination Plan for Young KidsMany Parents Worry That Kids Fell Behind in Schooling During PandemicNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsU.S. Pediatricians, Psychiatrists Declare 'Emergency' in Child Mental HealthState Spending on Poverty Really Pays Off for Kids: StudyNature Helped Many Kids Cope During Lockdown: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollKids Can Carry High, Infectious Levels of COVID CoronavirusBystanders Can Make the Difference for a Drowning ChildAs COVID Cases Drop, Fauci Tells Families to Enjoy HalloweenGolf Cart Injuries Keep Rising Among U.S. KidsStudy Confirms Rise in Child Abuse During COVID PandemicSocial Distancing Kept Kids From Getting Flu, RSVPfizer Seeks FDA Emergency Approval for COVID Vaccine in Younger KidsCould an App Help Kids With Severe Ear Condition Avoid Surgery?
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Pfizer Sends First Data to FDA on COVID Vaccines for Younger Kids

HealthDay News
by Steven Reinberg
Updated: Sep 28th 2021

new article illustration

TUESDAY, Sept. 28, 2021 (HealthDay News) -- Pfizer Inc. announced Tuesday that it has submitted initial data to federal regulators on the efficacy of its COVID-19 vaccine among younger children.

The company is also expected to submit the same data on kids aged 5 to 11 to the European Medicines Agency and other regulatory authorities in the next few weeks, CNN reported.

Last week, Pfizer released trial data that showed that the vaccine was safe and effective for children aged 5 to 11. That trial included nearly 2,300 participants who were given two doses of the vaccine 21 days apart.

The U.S. Food and Drug Administration has said that it could authorize a vaccine for younger children in a matter of weeks after the agency receives trial data. The FDA is expected to vet the vaccine through its panel of expert advisors before authorizing it, CNN noted.

If the FDA approves the vaccine for young kids, an advisory panel to the U.S. Centers for Disease Control and Prevention will then consider whether to recommend its use.

Nearly 28 million children aged 5 to 11 would be eligible for the vaccine in the United States, far more than the 17 million children aged 12 to 15 who became eligible for the vaccine in May, The New York Times reported. Only 42% of U.S. kids aged 12 to 15 have been fully vaccinated.

The same may hold true for the younger age group: A survey published last month by the Kaiser Family Foundation found that 26% of parents of children aged 5 to 11 would vaccinate their children immediately after they are eligible, while 40% said they would "wait and see" how the vaccine worked and 25% said they would not have their child vaccinated at all, the Times reported.

Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told CNN that, hopefully, vaccines can go into kids' arms by Halloween.

"The FDA takes very seriously the importance of getting vaccines shown to be safe and effective in children, to getting it into the arms of children, in this case, children from 11 down to 5," Fauci said on MSNBC's "Morning Joe" show on Tuesday. "The FDA, you never want to get ahead of their judgment, but I would imagine in the next few weeks, they will examine that data and hopefully they'll give the OK so that we could start vaccinating children, hopefully before the end of October."

Data on the immune response and safety for children ages 2 to 5, and 6 months to 2 years are expected "as soon as the fourth quarter of this year," Pfizer said, CNN reported.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on COVID vaccines.


SOURCES: CNN; The New York Times